VERVE THERAPEUTICS INC. - COMMON STOCK

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 июн 2025 13:05:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics to Participate in Upcoming Investor Conferences

28 май 2025 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results

14 май 2025 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 май 2025 13:05:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

14 апр 2025 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

11 апр 2025 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04 апр 2025 13:05:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose

24 мар 2025 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 мар 2025 13:05:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

27 фев 2025 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 фев 2025 13:05:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

29 янв 2025 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones

13 янв 2025 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08 янв 2025 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 янв 2025 13:05:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

29 ноя 2024 13:05:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

05 ноя 2024 04:00:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 ноя 2024 13:26:49 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 окт 2024 13:05:00 Источник Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 сен 2024 13:05:00 Источник Nasdaq GlobeNewswire